Loading...

Richard N Channick

Title(s)Professor of Clinical , Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
PhoneAppt: 310-825-8061 Admin: 310-825-5
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Inhaled Treprostinil in Group 3 Pulmonary Hypertension. N Engl J Med. 2021 May 13; 384(19):1870. Saggar R, Abtin F, Channick R. PMID: 33979498.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Significance of autoimmune disease in severe pulmonary hypertension complicating extensive pulmonary fibrosis: a prospective cohort study. Pulm Circ. 2021 Apr-Jun; 11(2):20458940211011329. Saggar R, Giri PC, Deng C, Johnson D, McCloy MK, Liang L, Shaikh F, Hong J, Channick RN, Shapiro SS, Lynch JP, Belperio JA, Weigt SS, Ramsey AL, Ross DJ, Sayah DM, Shino MY, Derhovanessian A, Sherman AE, Saggar R. PMID: 33996029.
      View in: PubMed   Mentions:
    3. United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol Design. JMIR Res Protoc. 2021 Apr 13. Kerr KM, Elliott CG, Benza RL, Channick RN, Chin K, Davis RD, Jain S, LaCroix A, Madani MM, McLaughlin VV, Park M, Tapson VF, Auger WR. PMID: 33848258.
      View in: PubMed   Mentions:
    4. Vascular Endobronchial Ultrasound in a Patient With Chronic Thromboembolic Pulmonary Hypertension. J Bronchology Interv Pulmonol. 2021 Apr 01; 28(2):e23-e26. Ghattas C, Channick RN, Wright CD, Vlahakes GJ, Channick C. PMID: 33753706.
      View in: PubMed   Mentions:    Fields:    
    5. The Pulmonary Embolism Response Team: Why and How? Semin Respir Crit Care Med. 2021 Feb 16. Channick RN. PMID: 33592652.
      View in: PubMed   Mentions:    Fields:    
    6. Relationship between time from diagnosis and morbidity/mortality in pulmonary arterial hypertension: results from the phase III GRIPHON study. Chest. 2021 Feb 02. Gaine S, Sitbon O, Channick RN, Chin KM, Sauter R, Galiè N, Hoeper MM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson V, Ghofrani HA, Lang I. PMID: 33545163.
      View in: PubMed   Mentions:    Fields:    
    7. NEDD9 is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation. Am J Respir Crit Care Med. 2021 Feb 01. Alba GA, Samokhin AO, Wang RS, Zhang YY, Wertheim BM, Arons E, Greenfield EA, Lundberg Slingsby MH, Ceglowski JR, Haley KJ, Bowman FP, Yu YR, Haney JC, Eng G, Mitchell RN, Sheets A, Vargas SO, Seo S, Channick RN, Leary PJ, Rajagopal S, Loscalzo J, Battinelli EM, Maron BA. PMID: 33523764.
      View in: PubMed   Mentions:    Fields:    
    8. Left main coronary artery compression in pulmonary hypertension. Catheter Cardiovasc Interv. 2020 Nov 25. Labin JE, Saggar R, Yang EH, Lluri G, Sayah D, Channick R, Ardehali A, Aksoy O, Parikh RV. PMID: 33241630.
      View in: PubMed   Mentions:    Fields:    
    9. Room for improvement in pulmonary capillary wedge pressure reporting: a review of hemodynamic tracings at a large academic medical center. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020929157. Johnson SW, Witkin A, Rodriguez-Lopez J, Channick R. PMID: 33240481.
      View in: PubMed   Mentions:
    10. Single-cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning. Am J Respir Crit Care Med. 2020 Oct 06. Hong J, Arneson D, Umar S, Ruffenach G, Cunningham CM, Ahn IS, Diamante G, Bhetraratana M, Park JF, Said E, Huynh C, Le T, Medzikovic L, Humbert M, Soubrier F, Montani D, Girerd B, Trégouët DA, Channick R, Saggar R, Eghbali M, Yang X. PMID: 33021809.
      View in: PubMed   Mentions:    Fields:    
    11. Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic: A Position Paper From the National PERT Consortium. Chest. 2020 12; 158(6):2590-2601. Rosovsky RP, Grodzin C, Channick R, Davis GA, Giri JS, Horowitz J, Kabrhel C, Lookstein R, Merli G, Morris TA, Rivera-Lebron B, Tapson V, Todoran TM, Weinberg AS, Rosenfield K. PMID: 32861692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Sex Differences in Portopulmonary Hypertension. Chest. 2021 Jan; 159(1):328-336. DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. PMID: 32798521.
      View in: PubMed   Mentions:    Fields:    
    13. Free-Floating Right Atrial Thrombus Removed by Aspiration Thrombectomy under Transesophageal Guidance. Am J Respir Crit Care Med. 2020 07 01; 202(1):e1-e2. Sherman AE, Moriarty JM, Yang EH, Ravi D, Chang SY, Channick RN. PMID: 32073897.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Unilateral Chronic Thromboembolic Pulmonary Disease: A Mimic of Pulmonary Artery Agenesis. Am J Respir Crit Care Med. 2020 05 15; 201(10):e74-e75. Hon S, Channick RN, Farber HW. PMID: 31899659.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Post-Intensive Care Unit Follow-up of Pulmonary Embolism. Crit Care Clin. 2020 Jul; 36(3):561-570. Jasuja S, Channick RN. PMID: 32473699.
      View in: PubMed   Mentions:    Fields:    
    16. Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study. J Heart Lung Transplant. 2020 04; 39(4):300-309. Sitbon O, Chin KM, Channick RN, Benza RL, Di Scala L, Gaine S, Ghofrani HA, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Tapson VF, Galiè N, Hoeper MM. PMID: 32061506.
      View in: PubMed   Mentions: 3     Fields:    
    17. Circulating NEDD9 is increased in pulmonary arterial hypertension: A multicenter, retrospective analysis. J Heart Lung Transplant. 2020 04; 39(4):289-299. Samokhin AO, Hsu S, Yu PB, Waxman AB, Alba GA, Wertheim BM, Hopkins CD, Bowman F, Channick RN, Nikolic I, Faria-Urbina M, Hassoun PM, Leopold JA, Tedford RJ, Ventetuolo CE, Leary PJ, Maron BA. PMID: 31952977.
      View in: PubMed   Mentions: 2     Fields:    
    18. COUNTERPOINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? No. Chest. 2019 12; 156(6):1043-1045. Channick RN, Saggar R. PMID: 31812189.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Rebuttal From Drs Channick and Saggar. Chest. 2019 12; 156(6):1047-1048. Channick RN, Saggar R. PMID: 31812191.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Quantification of the Pulmonary Vascular Response to Inhaled Nitric Oxide Using Noncontrast Computed Tomography Imaging. Circ Cardiovasc Imaging. 2019 12; 12(1):e008338. Rahaghi FN, Winkler T, Kohli P, Nardelli P, Martí-Fuster B, Ross JC, Radhakrishnan R, Blackwater T, Ash SY, de La Bruere I, Diaz AA, Channick RN, Harris RS, Washko GR, San José Estépar R. PMID: 30632391.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents. Chest. 2020 Apr; 157(4):955-965. McLaughlin VV, Channick R, De Marco T, Farber HW, Gaine S, Galié N, Krasuski RA, Preston I, Souza R, Coghlan JG, Frantz RP, Hemnes A, Kim NH, Lang IM, Langleben D, Li M, Sitbon O, Tapson V, Frost A. PMID: 31738929.
      View in: PubMed   Mentions: 1     Fields:    
    22. Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update. Drug Healthc Patient Saf. 2019; 11:71-85. Wong AK, Channick RN. PMID: 31564989.
      View in: PubMed   Mentions:
    23. Perfusion Imaging Distinguishes Exercise Pulmonary Arterial Hypertension at Rest. Am J Respir Crit Care Med. 2019 06 01; 199(11):1438-1441. Kohli P, Kelly VJ, Kehl EG, Rodriguez-Lopez J, Hibbert KA, Kone M, Systrom DM, Waxman AB, Venegas JG, Channick R, Winkler T, Harris RS. PMID: 30811948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplant Direct. 2019 Jun; 5(6):e456. DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. PMID: 31321292.
      View in: PubMed   Mentions:
    25. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Circulation. 2019 05 21; 139(21):2440-2450. Chin KM, Rubin LJ, Channick R, Di Scala L, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF. PMID: 30982349.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. The Identification and Management of Unsuspected Hemodynamically Unstable Pulmonary Embolism: The Need for Structured Multidisciplinary Teams. Can J Cardiol. 2019 07; 35(7):819-820. Chandy G, Channick R. PMID: 31292079.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Integrating Data From Randomized Controlled Trials and Observational Studies to Assess Survival in Rare Diseases. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005095. Torbicki A, Bacchi M, Delcroix M, Farber HW, Ghofrani HA, Hennessy B, Jansa P, Mehta S, Perchenet L, Pulido T, Rosenberg D, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Wei LJ, Channick R, Benza R. PMID: 31109190.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Capillary Proliferation in Systemic-Sclerosis-Related Pulmonary Fibrosis: Association with Pulmonary Hypertension. ACR Open Rheumatol. 2019 Mar; 1(1):26-36. Seki A, Anklesaria Z, Saggar R, Dodson MW, Schwab K, Liu MC, Charan Ashana D, Miller WD, Vangala S, DerHovanessian A, Channick R, Shaikh F, Belperio JA, Weigt SS, Lynch JP, Ross DJ, Sullivan L, Khanna D, Shapiro SS, Sager J, Gargani L, Stanziola A, Bossone E, Schraufnagel DE, Fishbein G, Xu H, Fishbein MC, Wallace WD, Saggar R. PMID: 31777777.
      View in: PubMed   Mentions:
    29. Critical Care of Patients After Pulmonary Thromboendarterectomy. J Cardiothorac Vasc Anesth. 2019 Nov; 33(11):3110-3126. Kratzert WB, Boyd EK, Saggar R, Channick R. PMID: 30948200.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient. Chest. 2019 03; 155(3):651-652. Channick CL, Channick RN. PMID: 30846074.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019 01; 53(1). Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. PMID: 30545971.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    32. Impact of chronic right ventricular pressure overload in short-term outcomes of acute pulmonary embolism: A retrospective analysis. J Crit Care. 2019 06; 51:1-5. Witkin A, Wilcox SR, Chang Y, Huang F, Dudzinski D, Zheng H, Channick R, Kabrhel C. PMID: 30673622.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study. Eur J Heart Fail. 2019 03; 21(3):352-359. Beghetti M, Channick RN, Chin KM, Di Scala L, Gaine S, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Galiè N. PMID: 30632656.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    34. Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619853037. Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, Blais D, Janicke D, Melamed R, Mohrien K, Rozycki E, Ross CB, Klein AJ, Rali P, Teman NR, Yarboro L, Ichinose E, Sharma AM, Bartos JA, Elder M, Keeling B, Palevsky H, Naydenov S, Sen P, Amoroso N, Rodriguez-Lopez JM, Davis GA, Rosovsky R, Rosenfield K, Kabrhel C, Horowitz J, Giri JS, Tapson V, Channick R. PMID: 31185730.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):31-40. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. PMID: 30242551.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    36. Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):41. Rosovsky R, Chang Y, Rosenfield K, Channick R, Jaff MR, Weinberg I, Sundt T, Witkin A, Rodriguez-Lopez J, Parry BA, Harshbarger S, Hariharan P, Kabrhel C. PMID: 30506351.
      View in: PubMed   Mentions:    Fields:    
    37. Management of Pulmonary Hemorrhage Complicating Pulmonary Thromboendarterectomy. Front Med (Lausanne). 2018; 5:326. Dalia AA, Streckenbach S, Andrawes M, Channick R, Wright C, Fitzsimons M. PMID: 30525040.
      View in: PubMed   Mentions:
    38. Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial. Chest. 2018 10; 154(4):848-861. Chin KM, Gomberg-Maitland M, Channick RN, Cuttica MJ, Fischer A, Frantz RP, Hunsche E, Kleinman L, McConnell JW, McLaughlin VV, Miller CE, Zamanian RT, Zastrow MS, Badesch DB. PMID: 29705220.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    39. Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial. PLoS One. 2018; 13(3):e0193226. Souza R, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BKS, Sitbon O, Torbicki A, Rubin LJ, Simonneau G. PMID: 29590122.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality. J Am Coll Cardiol. 2018 02 20; 71(7):752-763. McLaughlin VV, Hoeper MM, Channick RN, Chin KM, Delcroix M, Gaine S, Ghofrani HA, Jansa P, Lang IM, Mehta S, Pulido T, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Tapson VF, Perchenet L, Preiss R, Verweij P, Rubin LJ, Galiè N. PMID: 29447737.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    41. Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRIPHON Study. Am J Cardiovasc Drugs. 2018 Feb; 18(1):37-47. Coghlan JG, Channick R, Chin K, Di Scala L, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Gaine S. PMID: 29307087.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    42. Quantifying the learning curve for pulmonary thromboendarterectomy. J Cardiothorac Surg. 2017 Dec 28; 12(1):121. Sihag S, Le B, Witkin AS, Rodriguez-Lopez JM, Villavicencio MA, Vlahakes GJ, Channick RN, Wright CD. PMID: 29284512.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Does the Time of Day a Pulmonary Embolism Response Team Is Activated Affect Time to Intervention or Outcome? Chest. 2017 12; 152(6):1353-1354. McNeill JN, Witkin AS, Chang Y, Kabrhel C, Channick RN. PMID: 29223267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2017 10 15; 196(8):e32-e47. Talwar A, Garcia JGN, Tsai H, Moreno M, Lahm T, Zamanian RT, Machado R, Kawut SM, Selej M, Mathai S, D'Anna LH, Sahni S, Rodriquez EJ, Channick R, Fagan K, Gray M, Armstrong J, Rodriguez Lopez J, de Jesus Perez V. PMID: 29028375.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI2) Receptor Agonist in Pulmonary Arterial Hypertension (GRIPHON) study. J Heart Lung Transplant. 2018 03; 37(3):401-408. Preston IR, Channick RN, Chin K, Di Scala L, Farber HW, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, McLaughlin VV, Preiss R, Simonneau G, Sitbon O, Tapson VF, Rubin LJ. PMID: 29096938.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    46. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Eur Respir J. 2017 08; 50(2). Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galiè N, Ghofrani HA, Lang IM, McLaughlin V, Preiss R, Rubin LJ, Simonneau G, Sitbon O, Tapson VF, Hoeper MM. PMID: 28818881.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    47. Pulmonary Hypertension in a Patient with Hereditary Hemorrhagic Telangiectasia. R I Med J (2013). 2017 Aug 01; 100(8):29-31. Liu D, Sindhu K, Witkin A, Patel L, Channick R. PMID: 28759897.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 07; 101(7):1609-1615. DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. PMID: 28207639.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    49. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. Eur Heart J. 2017 04 14; 38(15):1147-1155. Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani HA, Le Brun FO, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. PMID: 28329315.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    50. The Pulmonary Embolism Response Team: What Is the Ideal Model? Semin Respir Crit Care Med. 2017 02; 38(1):51-55. Rodriguez-Lopez J, Channick R. PMID: 28208198.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    51. Impact of Pulmonary Arterial Clot Location on Pulmonary Embolism Treatment and Outcomes (90 Days). Am J Cardiol. 2017 03 01; 119(5):802-807. Jain CC, Chang Y, Kabrhel C, Giri J, Channick R, Rodriguez-Lopez J, Rosovsky RP, Fogerty A, Rosenfield K, Jaff MR, Weinberg I. PMID: 28153347.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension. Pulm Circ. 2016 Dec; 6(4):498-507. DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S. PMID: 28090291.
      View in: PubMed   Mentions:
    53. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016 Dec; 25(142):431-437. Olsson KM, Channick R. PMID: 27903665.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Electric Plasma-generated Nitric Oxide: Hemodynamic Effects in Patients with Pulmonary Hypertension. Am J Respir Crit Care Med. 2016 11 01; 194(9):1168-1170. Berra L, Rodriguez-Lopez J, Rezoagli E, Yu B, Fisher DF, Semigran MJ, Bloch DB, Channick RN, Zapol WM. PMID: 27797618.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial. Chest. 2017 Jan; 151(1):106-118. Mehta S, Sastry BKS, Souza R, Torbicki A, Ghofrani HA, Channick RN, Delcroix M, Pulido T, Simonneau G, Wlodarczyk J, Rubin LJ, Jansa P, Hunsche E, Galiè N, Perchenet L, Sitbon O. PMID: 27671974.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    56. New paradigm for pulmonary arterial hypertension treatment. Curr Opin Pulm Med. 2016 09; 22(5):429-33. Tamura Y, Channick RN. PMID: 27434819.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Pulmonary hypertension. Curr Opin Pulm Med. 2016 09; 22(5):399. Humbert M, Channick RN. PMID: 27428648.
      View in: PubMed   Mentions:    Fields:    
    58. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension. Ann Am Thorac Soc. 2016 07; 13 Suppl 3:S248-54. Pepke-Zaba J, Jais X, Channick R. PMID: 27571006.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    59. Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study. Am J Med. 2016 09; 129(9):978-985.e2. Tapson VF, Platt DM, Xia F, Teal SA, de la Orden M, Divers CH, Satler CA, Joish VN, Channick RN. PMID: 27046247.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    60. A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism. Chest. 2016 08; 150(2):384-93. Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T, Dudzinski DM, Rodriguez-Lopez J, Parry BA, Harshbarger S, Chang Y, Rosenfield K. PMID: 27006156.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    61. Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015 Dec 24; 373(26):2522-33. Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galiè N, Ghofrani HA, Hoeper MM, Lang IM, Preiss R, Rubin LJ, Di Scala L, Tapson V, Adzerikho I, Liu J, Moiseeva O, Zeng X, Simonneau G, McLaughlin VV, . PMID: 26699168.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    62. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. . 2015 Nov 01; 70(3):236-41. Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, Hsue PY, Chan SY. PMID: 26473639.
      View in: PubMed   Mentions:
    63. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J. 2015 Dec; 46(6):1711-20. Simonneau G, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun FO, Mehta S, Perchenet L, Pulido T, Sastry BK, Sitbon O, Souza R, Torbicki A, Rubin LJ. PMID: 26493786.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    64. Pulmonary Hypertension and Right Ventricular Failure in Emergency Medicine. Ann Emerg Med. 2015 Dec; 66(6):619-28. Wilcox SR, Kabrhel C, Channick RN. PMID: 26342901.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing. Pulm Circ. 2015 Sep; 5(3):580-6. DuBrock HM, Kradin RL, Rodriguez-Lopez JM, Channick RN. PMID: 26401260.
      View in: PubMed   Mentions:
    66. The changing paradigm in pulmonary hypertension trials: longer duration, new endpoints. Curr Opin Pulm Med. 2015 Sep; 21(5):438-45. LeVarge BL, Channick RN. PMID: 26176969.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Development of macitentan for the treatment of pulmonary arterial hypertension. Ann N Y Acad Sci. 2015 Nov; 1358:68-81. Selej M, Romero AJ, Channick RN, Clozel M. PMID: 26291180.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Chronic Thromboembolic Pulmonary Hypertension: the End Result of Pulmonary Embolism. Curr Cardiol Rep. 2015 Aug; 17(8):63. Witkin AS, Channick RN. PMID: 26099554.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. Eur Respir J. 2015 Aug; 46(2):405-13. McLaughlin V, Channick RN, Ghofrani HA, Lemarié JC, Naeije R, Packer M, Souza R, Tapson VF, Tolson J, Al Hiti H, Meyer G, Hoeper MM. PMID: 26113687.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    70. Improvement in severe pulmonary hypertension in obese patients after laparoscopic gastric bypass or sleeve gastrectomy. Surg Endosc. 2016 Feb; 30(2):633-637. Sheu EG, Channick R, Gee DW. PMID: 26091991.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Leaflet area as a determinant of tricuspid regurgitation severity in patients with pulmonary hypertension. Circ Cardiovasc Imaging. 2015 May; 8(5). Afilalo J, Grapsa J, Nihoyannopoulos P, Beaudoin J, Gibbs JS, Channick RN, Langleben D, Rudski LG, Hua L, Handschumacher MD, Picard MH, Levine RA. PMID: 25977303.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. What's new in the treatment of portopulmonary hypertension? Expert Rev Gastroenterol Hepatol. 2015 Jul; 9(7):983-92. DuBrock HM, Channick RN, Krowka MJ. PMID: 25882070.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Effect of macitentan on hospitalizations: results from the SERAPHIN trial. JACC Heart Fail. 2015 Jan; 3(1):1-8. Channick RN, Delcroix M, Ghofrani HA, Hunsche E, Jansa P, Le Brun FO, Mehta S, Pulido T, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A, Galiè N. PMID: 25457902.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    74. [Chronic thromboembolic pulmonary hypertension]. Turk Kardiyol Dern Ars. 2014 Oct; 42 Suppl 1:119-29. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. PMID: 25697039.
      View in: PubMed   Mentions:    Fields:    
    75. Chronic thromboembolic pulmonary hypertension: evolution in management. Curr Opin Pulm Med. 2014 Sep; 20(5):400-8. LeVarge BL, Channick RN. PMID: 25093673.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Macitentan for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2014 Aug; 8(4):393-9. DuBrock HM, Channick RN. PMID: 24998329.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension. Eur Respir J. 2014 Aug; 44(2):425-34. LeVarge BL, Pomerantsev E, Channick RN. PMID: 24925918.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    78. Case records of the Massachusetts General Hospital. Case 9-2014. A 34-year-old woman with increasing dyspnea. N Engl J Med. 2014 Mar 20; 370(12):1149-57. Saukkonen K, Tan TC, Sharma A, Channick RN, Murali MR, Zukerberg LR. PMID: 24645948.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    79. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014 Feb; 42(1):31-7. Provias T, Dudzinski DM, Jaff MR, Rosenfield K, Channick R, Baker J, Weinberg I, Donaldson C, Narayan R, Rassi AN, Kabrhel C. PMID: 24566594.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62(25 Suppl):D92-9. Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. PMID: 24355646.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansAnimals
    81. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013 Dec; 65(12):3194-201. Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, FitzGerald J, McLaughlin VV, . PMID: 24022584.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    82. Oral therapies for pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors. Clin Chest Med. 2013 Dec; 34(4):811-24. Channick R, Preston I, Klinger JR. PMID: 24267306.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    83. A multidisciplinary pulmonary embolism response team. Chest. 2013 Nov; 144(5):1738-1739. Kabrhel C, Jaff MR, Channick RN, Baker JN, Rosenfield K. PMID: 24189880.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    84. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013 Aug 29; 369(9):809-18. Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G, SERAPHIN Investigators . PMID: 23984728.
      View in: PubMed   Mentions: 242     Fields:    Translation:HumansCTClinical Trials
    85. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int. 2013 Oct; 84(4):682-92. Sise ME, Courtwright AM, Channick RN. PMID: 23739239.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    86. Combination therapy in pulmonary arterial hypertension. Am J Cardiol. 2013 Apr 16; 111(8 Suppl):16C-20C. Channick RN. PMID: 23558025.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    87. A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost. Pulm Circ. 2013 Apr; 3(2):381-8. Channick RN, Frantz RP, Kawut SM, Palevsky H, Tumuluri R, Sulica R, Lauto PO, Benton WW, de Boisblanc B. PMID: 24015339.
      View in: PubMed   Mentions:
    88. Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension. Pulm Circ. 2013 Apr; 3(2):369-80. Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB. PMID: 24015338.
      View in: PubMed   Mentions:
    89. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest. 2013 Feb 01; 143(2):324-332. McLaughlin VV, Langer A, Tan M, Clements PJ, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Pulmonary Arterial Hypertension-Quality Enhancement Research Initiative (PAH-QuERI) Investigators . PMID: 22910999.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    90. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension. Cardiovasc Ther. 2013 Feb; 31(1):38-44. Bourge RC, Tapson VF, Safdar Z, Benza RL, Channick RN, Rosenzweig EB, Shapiro S, White RJ, McSwain CS, Gotzkowsky SK, Nelsen AC, Rubin LJ. PMID: 22970909.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    91. Postradiofrequency ablation inflammatory pseudotumor associated with pulmonary venoocclusive disease: case report and review of the literature. Ann Diagn Pathol. 2013 Oct; 17(5):466-9. Kovach AE, Cheng GZ, Channick CL, Channick RN, Muniappan A, Gaissert HA, Kradin RL. PMID: 23352326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    92. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2012 Jun; 6(3):255-65. LeVarge BL, Channick RN. PMID: 22788940.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    93. Case records of the Massachusetts General Hospital. Case 11-2012. A 60-year-old man with weakness, rash, and renal failure. N Engl J Med. 2012 Apr 12; 366(15):1434-43. Channick RN, Lorenzo ME, Wu CC, Hoang MP. PMID: 22494124.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    94. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ. 2012 Apr-Jun; 2(2):139-47. Barst RJ, Channick R, Ivy D, Goldstein B. PMID: 22837854.
      View in: PubMed   Mentions:
    95. Inhaled treprostinil: a therapeutic review. Drug Des Devel Ther. 2012; 6:19-28. Channick RN, Voswinckel R, Rubin LJ. PMID: 22291467.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    96. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant. 2011 Dec; 30(12):1327-33. Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ. PMID: 22055098.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    97. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012 Feb; 71(2):249-52. Clements PJ, Tan M, McLaughlin VV, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A, Pulmonary Arterial Hypertension Quality Enhancement Research Initiative (PAH-QuERI) Investigators . PMID: 21998119.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    98. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest. 2012 Jan; 141(1):27-35. Kerr KM, Auger WR, Marsh JJ, Devendra G, Spragg RG, Kim NH, Channick RN, Jamieson SW, Madani MM, Manecke GR, Roth DM, Shragg GP, Fedullo PF. PMID: 21835900.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol. 2010 May 04; 55(18):1915-22. McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W. PMID: 20430262.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    100. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S85-S96. Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, Martinez FJ, Naeije R, Olschewski H, Pepke-Zaba J, Redfield MM, Robbins IM, Souza R, Torbicki A, McGoon M. PMID: 19555862.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    101. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S43-S54. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. PMID: 19555858.
      View in: PubMed   Mentions: 535     Fields:    Translation:Humans
    102. A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic pulmonary arterial hypertension. Circulation. 2009 May 05; 119(17):2313-22. Yu Y, Keller SH, Remillard CV, Safrina O, Nicholson A, Zhang SL, Jiang W, Vangala N, Landsberg JW, Wang JY, Thistlethwaite PA, Channick RN, Robbins IM, Loyd JE, Ghofrani HA, Grimminger F, Schermuly RT, Cahalan MD, Rubin LJ, Yuan JX. PMID: 19380626.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    103. Amplatzer device closure of a tortuous Gerbode (left ventricle-to-right atrium) defect complicated by transient hemolysis in an octogenarian. J Invasive Cardiol. 2008 Sep; 20(9):E273-6. Rothman A, Galindo A, Channick R, Blanchard D. PMID: 18762687.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    104. Hemodynamics and epoprostenol use are associated with thrombocytopenia in pulmonary arterial hypertension. Chest. 2009 Jan; 135(1):130-136. Chin KM, Channick RN, de Lemos JA, Kim NH, Torres F, Rubin LJ. PMID: 18719056.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    105. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus. 2008 Aug; 17(8):754-6. Hennigan S, Channick RN, Silverman GJ. PMID: 18625655.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    106. Exercise in patients with pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2008 Jan-Feb; 28(1):12-6. Desai SA, Channick RN. PMID: 18277824.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    107. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chest. 2007 Sep; 132(3):786-92. Chin KM, Channick RN, Kim NH, Rubin LJ. PMID: 17646224.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Sickle cell disease-associated pulmonary hypertension: a coat of many colors. Am J Respir Crit Care Med. 2007 Jun 15; 175(12):1218-9. McLaughlin VV, Channick R. PMID: 17545455.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    109. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. . 2007 May; 292(5):C1837-53. Remillard CV, Tigno DD, Platoshyn O, Burg ED, Brevnova EE, Conger D, Nicholson A, Rana BK, Channick RN, Rubin LJ, O'connor DT, Yuan JX. PMID: 17267549.
      View in: PubMed   Mentions:
    110. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest. 2006 Dec; 130(6):1657-63. Chin KM, Channick RN, Rubin LJ. PMID: 17166979.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    111. Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol. 2006 Oct 03; 48(7):1433-7. Channick RN, Olschewski H, Seeger W, Staub T, Voswinckel R, Rubin LJ. PMID: 17010807.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    112. Temporal trends and drug exposures in pulmonary hypertension: an American experience. Am Heart J. 2006 Sep; 152(3):521-6. Walker AM, Langleben D, Korelitz JJ, Rich S, Rubin LJ, Strom BL, Gonin R, Keast S, Badesch D, Barst RJ, Bourge RC, Channick R, Frost A, Gaine S, McGoon M, McLaughlin V, Murali S, Oudiz RJ, Robbins IM, Tapson V, Abenhaim L, Constantine G. PMID: 16923424.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    113. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006 Dec 01; 174(11):1257-63. McLaughlin VV, Oudiz RJ, Frost A, Tapson VF, Murali S, Channick RN, Badesch DB, Barst RJ, Hsu HH, Rubin LJ. PMID: 16946127.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    114. Sildenafil for pulmonary arterial hypertension. Future Cardiol. 2006 Mar; 2(2):137-43. Bartolome SD, Channick RN. PMID: 19804069.
      View in: PubMed   Mentions:    Fields:    
    115. Endothelin antagonism in pulmonary arterial hypertension. Semin Respir Crit Care Med. 2005 Aug; 26(4):402-8. Lee SH, Channick RN. PMID: 16121317.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    116. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J. 2004 Sep; 24(3):353-9. Humbert M, Barst RJ, Robbins IM, Channick RN, Galiè N, Boonstra A, Rubin LJ, Horn EM, Manes A, Simonneau G. PMID: 15358690.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCTClinical Trials
    117. Diagnosis and treatment of pulmonary arterial hypertension. Cardiol Clin. 2004 Aug; 22(3):441-52, vii. Channick R, Williamson TL. PMID: 15302363.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    118. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul; 126(1 Suppl):63S-71S. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J, American College of Chest Physicians . PMID: 15249495.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    119. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):68S-72S. Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, Kneussl M, Grimminger F. PMID: 15194181.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    120. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):62S-67S. Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. PMID: 15194180.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    121. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004 Apr; 23(4):595-600. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ. PMID: 15083760.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    122. Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in pulmonary arterial hypertension. Congest Heart Fail. 2004 Mar-Apr; 10(2 Suppl 2):7-10. Yung GL, Fedullo PF, Kinninger K, Johnson W, Channick RN. PMID: 15073478.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    123. Bosentan. Expert Rev Cardiovasc Ther. 2004 Mar; 2(2):175-82. Chin K, Channick R. PMID: 15151466.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation. 2004 Jan 06; 109(1):18-22. Kim NH, Fesler P, Channick RN, Knowlton KU, Ben-Yehuda O, Lee SH, Naeije R, Rubin LJ. PMID: 14699009.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    125. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003 Nov; 76(5):1457-62; discussion 1462-4. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. PMID: 14602267.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    126. Successful withdrawal of long-term epoprostenol therapy for pulmonary arterial hypertension. Chest. 2003 Oct; 124(4):1612-5. Kim NH, Channick RN, Rubin LJ. PMID: 14555600.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    127. Decreased plasma neurohormones and improved cardiac performance after surgical treatment of chronic pulmonary embolism. Ann Thorac Surg. 2003 Jul; 76(1):287-90. Tulevski II, Bresser P, Hirsch A, Groenink M, Channick RN, Jamieson SW, Mulder BJ. PMID: 12842565.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    128. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest. 2003 Jul; 124(1):247-54. Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G, Tapson VF, Rubin LJ. PMID: 12853530.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    129. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Jun 18; 41(12):2119-25. Barst RJ, McGoon M, McLaughlin V, Tapson V, Rich S, Rubin L, Wasserman K, Oudiz R, Shapiro S, Robbins IM, Channick R, Badesch D, Rayburn BK, Flinchbaugh R, Sigman J, Arneson C, Jeffs R, Beraprost Study Group . PMID: 12821234.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    130. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2003 Apr 16; 41(8):1380-6. Galiè N, Hinderliter AL, Torbicki A, Fourme T, Simonneau G, Pulido T, Espinola-Zavaleta N, Rocchi G, Manes A, Frantz R, Kurzyna M, Nagueh SF, Barst R, Channick R, Dujardin K, Kronenberg A, Leconte I, Rainisio M, Rubin L. PMID: 12706935.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    131. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J. 2003 Jan; 21(1):31-6. Fesler P, Pagnamenta A, Vachiéry JL, Brimioulle S, Abdel Kafi S, Boonstra A, Delcroix M, Channick RN, Rubin LJ, Naeije R. PMID: 12570105.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    132. Outpatient inhaled nitric oxide in a patient with idiopathic pulmonary fibrosis: a bridge to lung transplantation. J Heart Lung Transplant. 2001 Nov; 20(11):1224-7. Yung GL, Kriett JM, Jamieson SW, Johnson FW, Newhart J, Kinninger K, Channick RN. PMID: 11704484.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    133. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001 Oct 06; 358(9288):1119-23. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. PMID: 11597664.
      View in: PubMed   Mentions: 258     Fields:    Translation:HumansCTClinical Trials
    134. Pulmonary vasoreactivity in PPH. J Am Coll Cardiol. 2001 Oct; 38(4):1267-8. Robbins IM, Barst RJ, Channick RN, Rubin LJ. PMID: 11587028.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    135. New and experimental therapies for pulmonary hypertension. Clin Chest Med. 2001 Sep; 22(3):539-45. Channick RN, Rubin LJ. PMID: 11590847.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    136. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2001 Sep; 22(3):561-81. Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. PMID: 11590849.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    137. A new era in the treatment of primary pulmonary hypertension. Heart. 2001 Mar; 85(3):251-2. Bailey CL, Channick RN, Rubin LJ. PMID: 11179256.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    138. Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study. J Heart Lung Transplant. 2001 Feb; 20(2):262-263. Channick R, Badesch DB, Tapson VF, Simonneau G, Robbins I, Frost A, Roux S, Rainisio M, Bodin F, Rubin LJ. PMID: 11250530.
      View in: PubMed   Mentions: 18     Fields:    
    139. "High probability" perfusion lung scans in pulmonary venoocclusive disease. Am J Respir Crit Care Med. 2000 Nov; 162(5):1974-8. Bailey CL, Channick RN, Auger WR, Fedullo PF, Kerr KM, Yung GL, Rubin LJ. PMID: 11069842.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    140. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 2000 Jul; 162(1):14-20. Kerr KM, Auger WR, Marsh JJ, Comito RM, Fedullo RL, Smits GJ, Kapelanski DP, Fedullo PF, Channick RN, Jamieson SW, Moser KM. PMID: 10903213.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    141. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res. 2000 Jun; 26(4):287-301. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. PMID: 10923246.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    142. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J. 2000 Apr; 15(4):640-8. Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. PMID: 10780753.
      View in: PubMed   Mentions: 22     Fields:    Translation:Animals
    143. The natural history of acute and chronic thromboembolic disease: the search for the missing link. Eur Respir J. 2000 Mar; 15(3):435-7. Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. PMID: 10759432.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    144. Combination therapy for pulmonary hypertension: a glimpse into the future? Crit Care Med. 2000 Mar; 28(3):896-7. Channick RN, Rubin LJ. PMID: 10752856.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    145. Identifying the cause of unilateral hypoperfusion in patients suspected to have chronic pulmonary thromboembolism: diagnostic accuracy of helical CT and conventional angiography. Radiology. 1999 Dec; 213(3):743-9. Bergin CJ, Hauschildt JP, Brown MA, Channick RN, Fedullo PF. PMID: 10580948.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    146. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg. 1999 Nov; 68(5):1770-6; discussion 1776-7. Mo M, Kapelanski DP, Mitruka SN, Auger WR, Fedullo PF, Channick RN, Kerr K, Archibald C, Jamieson SW. PMID: 10585057.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    147. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol. 1999 Sep 15; 84(6):682-6. Rothman A, Sklansky MS, Lucas VW, Kashani IA, Shaughnessy RD, Channick RN, Auger WR, Fedullo PF, Smith CM, Kriett JM, Jamieson SW. PMID: 10498139.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    148. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999 Aug; 160(2):523-8. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. PMID: 10430723.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    149. Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 1999 Apr; 11(2):179-90. Auger WR, Channick RN, Kerr KM, Fedullo PF. PMID: 10378862.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    150. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med. 1998 May; 157(5 Pt 1):1690-3. Yung GL, Channick RN, Fedullo PF, Auger WR, Kerr KM, Jamieson SW, Kapelanski DP, Moser KM. PMID: 9603156.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    151. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. AJR Am J Roentgenol. 1997 Jun; 168(6):1549-55. Bergin CJ, Hauschildt J, Rios G, Belezzuoli EV, Huynh T, Channick RN. PMID: 9168722.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    152. Inhaled nitric oxide (40 ppm) during one-lung ventilation, in the lateral decubitus position, does not decrease pulmonary vascular resistance or improve oxygenation in normal patients. J Cardiothorac Vasc Anesth. 1997 Apr; 11(2):172-6. Wilson WC, Kapelanski DP, Benumof JL, Newhart 2nd JW, Johnson FW, Channick RN. PMID: 9105988.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    153. Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol. 1996 Sep 01; 78(5):584-7. Bradley SP, Auger WR, Moser KM, Fedullo PF, Channick RN, Bloor CM. PMID: 8806351.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    154. Unilateral pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence? Am J Respir Crit Care Med. 1996 Aug; 154(2 Pt 1):491-6. Hirsch AM, Moser KM, Auger WR, Channick RN, Fedullo PF. PMID: 8756827.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    155. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest. 1996 Aug; 110(2):399-403. Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, Moser KM. PMID: 8697841.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    156. Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests. Chest. 1996 Jun; 109(6):1545-9. Channick RN, Newhart JW, Johnson FW, Williams PJ, Auger WR, Fedullo PF, Moser KM. PMID: 8769509.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    157. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 1995 Jun; 16(2):353-74. Fedullo PF, Auger WR, Channick RN, Moser KM, Jamieson SW. PMID: 7656546.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    158. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. A practical nitric oxide delivery and monitoring system. Chest. 1994 Jun; 105(6):1842-7. Channick RN, Newhart JW, Johnson FW, Moser KM. PMID: 8205886.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    159. Improvement in pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):811-4. Channick RN, Hoch RC, Newhart JW, Johnson FW, Smith CM. PMID: 8118653.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    160. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg. 1993 Jul; 106(1):116-26; discussion 126-7. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, Moser KM. PMID: 8320990.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    Richard's Networks
    Concepts (434)
    Derived automatically from this person's publications.
    _
    Co-Authors (47)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _